Leukemia, 0887-6924
Journal
21 - 30 out of 63Page size: 10
Publications
- 2014
- Published
A multi-centre phase 2 study of azacitidine in chronic myelomonocytic leukaemia
Pierre Cauchy, Peter Cockerill, Jul 2014, In: Leukemia. 28, 7, p. 1570-1572 3 p.Research output: Contribution to journal › Letter › peer-review
- Published
Delineating MEIS1 cis-regulatory elements active in hematopoietic cells
Conny Bonifer, Peter Cockerill, Feb 2014, In: Leukemia. 28, 2, p. 433-436 4 p.Research output: Contribution to journal › Letter › peer-review
- Published
IMWG consensus on risk stratification in multiple myeloma
Keith Wheatley, Feb 2014, In: Leukemia. 28, 2, p. 269-77 9 p.Research output: Contribution to journal › Article › peer-review
- 2013
- Published
Novel therapies for children with acute myeloid leukaemia
Pamela Kearns, 1 Jul 2013, In: Leukemia. 27, 7, p. 1451-1460 10 p.Research output: Contribution to journal › Article › peer-review
- Published
- Published
The addition of gemtuzumab ozogamicin to low-dose Ara-C improves remission rate but does not significantly prolong survival in older patients with acute myeloid leukaemia: Results from the LRF AML14 and NCRI AML16 pick-a-winner comparison
Robert Hills, Keith Wheatley, 1 Jan 2013, In: Leukemia. 27, 1, p. 75-81 7 p.Research output: Contribution to journal › Article › peer-review
- 2012
- Published
Depletion of RUNX1/ETO in t(8;21) AML cells leads to genome-wide changes in chromatin structure and transcription factor binding
Anetta Ptasinska, Salam Assi, Maarten Hoogenkamp, Pierre Cauchy, Peter Cockerill & Conny Bonifer, 1 Aug 2012, In: Leukemia. 26, 8, p. 1829-1841Research output: Contribution to journal › Article › peer-review
- Published
Quantification of subclonal distributions of recurrent genomic aberrations in paired pre-treatment and relapse samples from patients with B-cell chronic lymphocytic leukemia
Jean-Baptiste Cazier, Jul 2012, In: Leukemia. 26, 7, p. 1564-75 12 p.Research output: Contribution to journal › Article › peer-review
- Published
Extreme telomere erosion in ATM-mutated and 11q-deleted CLL patients is independent of disease stage
Victoria Weston, Tatjana Stankovic, 1 Apr 2012, In: Leukemia. 26, 4, p. 826-830 5 p.Research output: Contribution to journal › Article
- Published
Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study
Sudhesh Kumar & 6 others, , Jan 2012, In: Leukemia. 26, 1, p. 149-57 9 p.Research output: Contribution to journal › Article › peer-review